Glutamic Acid Decarboxylase Antibodies

Assay |
Glutamic acid decarboxylase (GAD) antibodies |
Key Words |
Glutamic acid decarboxylase antibodies, GAD |
Specimen Collection |
Serum (brown) |
Turnaround time |
28 days |
Test indications |
GAD antibodies are found in 60% of patients with Stiff man syndrome, usually with high titre. These antibodies are also found in up to 80% of patients with recent onset Type 1 Diabetes Mellitus. However these antibodies reduce with disease duration. In the assessment of first degree relatives for autoimmune diabetes, positive results in more than one of the marker antibodies (GAD, Islet cell, IA-2 or insulin) can be associated with the onset of autoimmune diabetes. GAD antibodies are not available as a routine test in established diabetes. |
Methodology |
ELISA |
Interferences |
No known methodological interferences |
Reference Range |
Negative <10 IU/mL Positive ≥10 U/mL |
Analytical error |
Contact laboratory (x8454) |
Reference change value |
N/A |